Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myelomaEhsan Malek, James J. Driscoll|Leukemia|2016Cited by 56
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trialEhsan Malek, James J. Driscoll|Nature Communications|2024Cited by 23